Targeted Oncology1 小时
FDA OKs TLX007-CDx in Prostate Cancer Treatment
TLX007-CDx is a cold kit designed for the preparation of PSMA-targeted PET imaging for prostate cancer. It leverages ...
Illuccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in ...
MELBOURNE, Australia and PORTO ALEGRE, Brazil, March 18, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, ...
Transparency Market Research1 天
Medical Isotopes Market
Explore the medical isotopes market growth, trends, innovations, and applications in healthcare, diagnostics, and therapy. Discover key drivers, challenges, and opportunities shaping the industry.
Dr. Krishnan Suthanthiran Receives Lifetime Achievement Award From CRT For Contributions To ...
TeamBest Global Companies logo - 2025 CRT Lifetime Achievement Award Brachytherapy Research & Educational Foundation (BREF) ...
Telix Pharmaceuticals Limited: Illuccix Approved for Prostate Cancer Imaging in Brazil ...
MELBOURNE, Australia and PORTO ALEGRE, Brazil, March 18, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the Brazilian Health ...
Yahoo Finance3 天
Telix Pharmaceuticals Limited (TLX)
MELBOURNE, Australia, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) today announces that it has completed the installation of two new ...